{"name":"HilleVax","slug":"hillevax","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5USGZ6b1NibGFmQmQ1OW1Gd2V4b0lqYXlyNVo5WGZhLV9IT043VXFmUkxIdXBVb0NIb1YxZF9hR1I4NkozM2ZNcHJabE1OZVNuUUZR?oc=5","date":"2025-08-04","type":"pipeline","source":"FirstWord Pharma","summary":"Struggling HilleVax, LAVA find saviour in XOMA Royalty - FirstWord Pharma","headline":"Struggling HilleVax, LAVA find saviour in XOMA Royalty","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQTGlISTR5LW1NcmMyWnlSZEROSm1JWGlzbnpLTzNuTmJhZVpjcTdjRC1faFktT2Rjb09wRF93RnlQbmtyVW4xYTc3b3EzcTFjZEVSdW1UTFlGTzFjbV9CMXM2SXZaaUJncm9aa1JqM001cDBlWGhNMm9JT01IZDVQdks4SHZDZFBfZEtPUHdtdzVCYlQ0?oc=5","date":"2025-08-04","type":"deal","source":"BioPharma Dive","summary":"Xoma strikes deals to buy struggling biotechs HilleVax, Lava - BioPharma Dive","headline":"Xoma strikes deals to buy struggling biotechs HilleVax, Lava","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxNOFhvMkptdC1LU3FCU29lOGpRWDBvbk13R2pyOXU0UWl5dTlsWklQWmdFZ2FMRktqQlprUWhTcURMcExsUDJLdVBIZTFobUZjbnFQT2lvc1c5UFhmb1h2VjQ3a19oWDMyekdSZHc2dThGUHR0NThFQ2pJeGxBTFZXakh0Y2lpOWhGRlhxeGpBX0U2Sk1WclVQeDN5TEM4Wl9rcElRNkEwOXQ4SUh2S2Q2bQ?oc=5","date":"2025-04-17","type":"deal","source":"businesswire.com","summary":"Frazier Life Sciences Appoints Aditya Kohli to Partner - businesswire.com","headline":"Frazier Life Sciences Appoints Aditya Kohli to Partner","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxNU2xXWklUN1dGSEFTY2NKc2NFOGM0TE9FUmttOU1nb1hRUTltTjdXWEtlTGhpMkRSbXozU1ctUFZjU3J5TGZKV0MxblYtRk1GNUtETmR4bjBKbXBMbnR4VkpWamg0VGdhTXFUY1hSUTdYM3lCQmlnRFMwSHlYYWFkWmRldWFOSUZzWXJGWmpIQmlqYmg4T0pUR3hpeWkwN3hwODBNQ2ZvcGdpRnB6TmdNQXdPQ1RNUDY0OFE?oc=5","date":"2024-08-01","type":"trial","source":"Pharmaceutical Technology","summary":"HilleVax slashes workforce by 40% after norovirus vaccine trial failure - Pharmaceutical Technology","headline":"HilleVax slashes workforce by 40% after norovirus vaccine trial failure","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMi7wFBVV95cUxQTmVrakktWTRqNVNicFhKclZuRHpfNkwtam1hb0k0eU1wOWRnTjM0VGdvRm4zTmFjSl9GLUhkc1JRcXZFTE1MOHR3bXBPOE1pTFhMQXc1Mlp4aFRBenNHSFJfTnhFTFdNaUtFV0FTdldNd0NfazJtOWlieDlEOGhyb19EUTQyNE9KTUlnZ3lEcFYtLVVfdFkxU192VUdTdmtKdjJILXhOUkEzSy05aGpsbVZ6dlBBS2ZWNjdpTUpic0p3ak9QS1g3S3Jkd2VUZUpSMVg1dmxKa2ZlUHNYdzUzWnhsLVBwSXZMZnBfX2oxY9IB9AFBVV95cUxOb1dMMnc0WWlyLVR1djdjTDBFQ29sc1FSQWxKOHV4dk5odTRWLXR5MUp6MTVDY3BPbm9DWTRsREFqRUVOTUtjVTB2T3ljYUZ6ZkxuMmVOckQ2YjRXVlZZZXVla2F4NnlKVVlWZ1V2dUxSV3VNSkY1N3dXY2lMNi1pNHVrWE5LLUh4TkxIcEVyWmJSbmxIQmpSWkRxLTI5Nlh0eHdCdUtSd2R1LTJUcFVjTGpCM0hOaVN6eFVCRmF0VlRWbHBYNVpQdnU4NkZDTU5ya3JoeFk4YURJYzVHVEpIWng0VEtKSWlLaF9va3h6d2d3cVNG?oc=5","date":"2024-07-09","type":"pipeline","source":"ET Pharma","summary":"HilleVax to discontinue development of norovirus vaccine for infants; shares plummet - ET Pharma","headline":"HilleVax to discontinue development of norovirus vaccine for infants; shares plummet","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxQQUIxaTFCUVA0TW9OTXZCNjVSeFlWeGFCamhST01MdUdsdUNYUkJUTjRmM0ljQjlwNjJPaFZDejdCT1liUkZnYlc1dEVWSnFVWS1TRUpmUGg2VklxUjRyNmVwTUU4bjhFdTZUZExKQ2xybnQ5U2p3Z1l1ZEZURHhzdjYzb095X2laU2pLQXpyY0dLM3I1SEZF?oc=5","date":"2024-07-08","type":"pipeline","source":"MedCity News","summary":"A No-Go for HilleVax as Norovirus Vaccine Fails Mid-Stage Test in Infants - MedCity News","headline":"A No-Go for HilleVax as Norovirus Vaccine Fails Mid-Stage Test in Infants","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxQNzFudjVaMGN1UHdOU3ktalVvNl9YU1A2YWFMWFVoQk96eUFoQ3ViazROeTJaVWVtdkZsUVpMNFdqeE9ONEgzN1VENUxjUElNLWloNlpSeW9UTi1oc3dGWklnSFNSNnRmcjFaM0FhMjZQR0Q0Z1pOc2RJVW5QZjJxdVlwNlNTS0ZMSDNYcjJUSGxoYnVzXzU0?oc=5","date":"2024-07-08","type":"trial","source":"BioPharma Dive","summary":"HilleVax’s norovirus vaccine ineffective in large trial of infants - BioPharma Dive","headline":"HilleVax’s norovirus vaccine ineffective in large trial of infants","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxNNDdrVFZGMTA5UjBfS2xmYjdmQkVjUmgxaEdsSDdmNl8xQWhJZ3U0Z1VQVTgzNjVpRkNoUHdpaldsbFJncVY3WVlMZFZtTHZyZnl0d0VGT1pYbWhCZ1VFLUJxaWxrdmF2OEpSSWJfTWtjRVJUVlBaT3NRdGZsbE85WGd3elZGZW9BYU1XNjRjV3dzUl9acVk4WmdvQXc0bXJVdGxENncwWmFmcVZtWVJzb2Faakw0WG1JeDR4UkRXajd0OFk?oc=5","date":"2024-07-08","type":"trial","source":"Fierce Biotech","summary":"Takeda spinout HilleVax sees stock sink 80% as norovirus vaccine flunks phase 2 trial in infants - Fierce Biotech","headline":"Takeda spinout HilleVax sees stock sink 80% as norovirus vaccine flunks phase 2 trial in infants","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxOMHpEWjA3YjBCTFR4SThzWGlBbmJwbnVDazZlbjJXdzVYZEJEenEyeVM0d202cmdicHpYR0FPX2tENGFNRzRDV3hFb2FIQkh5VnpuamRWLTJQVlE1THRwd0Q0Uk9EemI0bGp6RzZZUDlfbnFoNlNvSnRxUEVHSWJ4Q3RfOWpqZjZMbTFLVElFWWwweFExZGVBeFJ6cGxKdnZRZklPdVlJakQ1akdSbHYyUg?oc=5","date":"2021-09-08","type":"pipeline","source":"Fierce Biotech","summary":"Takeda's norovirus vaccine spinout, HilleVax, secures $135M crossover - Fierce Biotech","headline":"Takeda's norovirus vaccine spinout, HilleVax, secures $135M crossover","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxPZ0xIcndUc0J5RDQ3SUJmUHhzVUNTQzJVYmFSOFpsTVJHQ19YclVUT08xdV9yQzllOF92SGtaUVlZMGNFZGVyajV1NThGZ2RVcC1DVkc1TXA5RzhlMnJHNjVvU0E0N1g3MXhic3ZxSDJWbDBXNllZdVNfRUpKanE1NFl2UnVQQQ?oc=5","date":"2021-07-30","type":"pipeline","source":"Pharmaceutical Technology","summary":"Takeda and Frazier to launch HilleVax for norovirus vaccine development - Pharmaceutical Technology","headline":"Takeda and Frazier to launch HilleVax for norovirus vaccine development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxNOHlCa1ViTnBqQ3pRTU1CVmVFZGVrX3NhbGtpWHpXNHN6Mlp6NXMxeUNvVUZ1aEUwa0pHelprNVFFZGFqRmdOblFFb0gxRlBiWFFuaXVmU2UzSm05V1l1S3p4Rl9VdHliMXFxbHZKWjhiYlgzUmE1Q0FwR3lxc1JCZGtCSGpSZlBOQmNYeW9Fbw?oc=5","date":"2021-07-30","type":"pipeline","source":"pharmaphorum","summary":"Takeda spins norovirus vaccine out into separate company - pharmaphorum","headline":"Takeda spins norovirus vaccine out into separate company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogJBVV95cUxNQXJlblU3b2xZZkJ5bmxZUnViUWt4T3N1Y05wRlFmWFBxdEE0S1hhNnJQSEFESENzTlRqODJFYV8tdWRUQlR3eTBHTm8xdjFUbWFGeFZ0ZWx2NXlzVDFGeTcxM3FKN2RJRGJwcmltNlhaOXpMeWF0Ym5JMXA4dndXbEpiYzIzNWdrSHBoTFJYNTMwZHlFQ1JEdk5Zcmx3RS1oZkVyZlEtTzNWRk9UYUdMVVRTenlzUkdhTF9ZajVyWS1MRFBOTThwdThkMWpwUXloa1ZEMzdoNC1TZGdrVW9YVmRxYkE4Mnl0S0NXa1lYR1l2ZnVQMkk0UkFyTVhxZ0lmN3JKN3NlLTRLbldKd0hBQUFXMGl5U19CVDVuWHg5ek9oQQ?oc=5","date":"2021-07-29","type":"deal","source":"businesswire.com","summary":"Takeda and Frazier Healthcare Partners Announce Collaboration to Launch HilleVax, Inc. to Develop Clinical Stage Norovirus Vaccine Candidate - businesswire.com","headline":"Takeda and Frazier Healthcare Partners Announce Collaboration to Launch HilleVax, Inc. to Develop Clinical Stage Norovir","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}